Skip to main content
. Author manuscript; available in PMC: 2021 Feb 1.
Published in final edited form as: Osteoarthritis Cartilage. 2019 Oct 16;28(2):137–145. doi: 10.1016/j.joca.2019.10.001

Table 4.

Association between Tramadol Initiation and Risk of Incident Myocardial Infarction within Six-month Follow-up Comparing with Initiation of Codeine among Patients with Osteoarthritis

Tramadol Codeine
Primary analysis
 Participants (n) 42,722 42,722
 Incident myocardial infarction (n) 127 103
 Mean follow-up (year) 0.49 0.49
 Rate (1000 person-years)* 6.1 5.0
 RD (1000 person-years, 95% CI) 1.1 (−0.3, 2.5) 0.0 (reference)
 HR (95% CI) 1.23 (0.95, 1.60) 1.00 (reference)
“As-treated” approach**
 Participants (n) 42,722 42,722
 Incident myocardial infarction (n) 66 47
 Mean follow-up (year) 0.25 0.21
 Rate (1000 person-years) 6.2 5.1
 RD (1000 person-years, 95% CI) 1.1 (−1.0, 3.2) 0.0 (reference)
 HR (95% CI) 1.21 (0.83, 1.76) 1.00 (reference)
Incident OA patients
 Participants (n) 25,104 25,104
 Incident myocardial infarction (n) 60 59
 Mean follow-up (year) 0.49 0.49
 Rate (1000 person-years) 4.9 4.8
 RD (1000 person-years, 95% CI) 0.1 (−1.7, 1.8) 0.0 (reference)
 HR (95% CI) 1.01 (0.71, 1.45) 1.00 (reference)
Missing data imputation
 HR (95% CI) 1.13 (0.88, 1.46) 1.00 (reference)
Conventional covariate adjustment approach
 HR (95% CI) 1.16 (0.92, 1.47) 1.00 (reference)

RD, rate difference; HR, hazard ratio; n, number; 95% CI, 95% confidence interval; OA, osteoarthritis.

*

Number (rate) of competing event (i.e., death) in tramadol and codeine cohort was 791 (38.0/1000 person-years) and 822 (39.6 /1000 person-years), respectively.

**

82% and 89% participants discontinued or switched their initiated treatment in tramadol and codeine cohort, respectively.